Sociology contribution to understanding the (no)diffusion of a medical innovation
- document 1 document 2 document 3
- niveau 1 niveau 2 niveau 3
- audio 1 audio 2 audio 3
Descriptif
Interfacetechnology/clinical/SHS/public health : case study interventional radiology
We will present results of an undergoing study on the socioeconomic processes of recognition in oncology of a long-standing medical innovation, the so-called interventional radiology (IR). This project is conducted by a multidisciplinary team gathering health sociologist, sociologist of science, economist of innovation, health lawyer and interventional radiologist, supported by INCa. With scientometrics and patent landscaping, we get an understanding of the IR discoveries’ chronology and identify the relationships established between science, medicine and industry. Through field observations and semi-directed interviews, we analyzed the strategies of legitimation of IR, seeking to show how each social groups (physicians, hospital, public agency, industry, …) participate together or not in IR recognition and therefore built the normative framework for this innovative medical practice.
Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.
Thèmes
Notice
Dans la même collection
-
BRIO support to scientistsDessisDamien
BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research
-
-
Translational cancer genomics and proteomicsSleijferStefan
Translational science : how to move from biology to clinical applications Evaluation of cell-free DNA (cfDNA) is a very attractive tool to serve as “liquid biopsy” to define and establish
-
Curing leukemia ?MahonFrançois-Xavier
Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid
-
Cost-effectiveness analysis for decision making, illustrated theoryBénardAntoine
Interface technology/clinical/SHS/public health : case study interventional radiology In a health care system with limited resources, each euro invested in a health care intervention is no longer
-
BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate tSoubeyranPierre
Update the implementation of BRIO Brio organisation is now fully up and running, and more than 100 research projects are currently active into the 6 integrated research programmes. In addition,
-
Expert panel discussions : why translational research matters
En point d'orgue du Scientific BRIO Day, David Cameron, spécialiste reconnu en Oncologie, Professeur à l'Université d'Edimbourg, anime un débat sur la question de la recherche dite translationnelle,
Sur le même thème
-
JPS 2017 / Dépistage en médecine générale
Journées des Professionnels de Santé 2017 Formation Médicale Continue des Médecins Généralistes >> Yves-Marie Vincent : Dépistage du cancer du sein >> Emmanuel Prothon et
-
A combined laser microdissection and mass spectrometry method for proteomic analysis of tissue sectiRaymondAnne-Aurélie
Clinical and biological samples : opportunities and challenges for translational research A challenge in oncology is to better define the tumor of the patient to study the pathology and of course
-
Life of a sampleMerlioJean-Philippe
Clinical and biological samples : opportunities and challenges for translational research The first purpose of this talk is to provide ton non clinical researchers some main technical, ethical
-
From the OR to clinical database... what for ? The example of UroCCRBernhardJean-Christophe
Clinical and biological samples : opportunities and challenges for translational research The UroCCR database was created to respond to the need on centralization and sharing of the multiple
-
Modelling prognostic capabilities of tumor size : application to colorectal cancerRondeauVirginie
Epidemiology and public health In oncology, the international WHO and RECIST criteria have allowed the standardization of tumor response evaluation in order to identify the time of disease
-
Social inequalities impacts of care management and survival in patients with non-hodgkin lymphomasLe Guyader-PeyrouSandra
Epidemiology and public health The principal aim of this thesis will describe the care pathway of diffuse large B cell lymphoma (DBCL) and follicular lymphoma (FL) in the general population and
-
How studying hematological malignancies subtypes may inform epidemiologic and clinical researchMonnereauAlain
Epidemiology and public health The aim of the talk entitled "How studying hematological malignancies (HM) subtypes may inform epidemiologic and clinical research" is to bring to the audience
-
A new weapon against the tobacco industry : class action lawsuit using a novel epidemiologic parameSiemiatyckiJack
Epidemiology and public health Lawsuits against the tobacco industry, if successful, have the potential to compensate victims of smoking and to diminish the capacity of the tobacco industry to
-
Flash talk - Call for proposal FAC 2014ElustondoFrédéricWodrichHaraldFaustinBenjaminSaltelFrédéricCognetLaurent
Personalized breast cancer therapy based on viral functional assays to score pathway activity Harald Wodrich, University of Bordeaux State-of-the-art mass sequencing technology has paved the road
-
BRIO supporting action to integrated cancer research in BordeauxMeoniPaolo
About BRIO Siric challenges and actions The success of BRIO’s approach and the realization of its potential impact on the translational research community in Bordeaux rely both on the efficient
-
Sarcoma Database: a unique tool for research on mesenchymal tumorsCoindreJean-Michel
Clinical biology session The main sarcoma databases are the Conticabase (https://conticabase.sarcomabcb.org) and the ConticaGist (https://conticagist.sarcomabcb.org) with 18000 patients and which
-
BRIO strategic challenges and the implementation of a translational culture in BordeauxSoubeyranPierre
About BRIO Siric challenges and actions BRIO’s strategic objective is to strengthen Bordeaux’s leadership in Cancer Research through the creation of a dynamic cancer research community, the
